ArticleCancer chemotherapy and pharmacology2017

Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer.

Andrea Rocca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.